Ian F. Smith, EVP, CFO & COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 133,750 shares at $161.00 ($21.5M) on 2017-07-19, disclosed to the SEC on 2017-07-21.
Open-market sale of $21.5M VRTX by EVP, CFO & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $161.00 | 123,400 | $19.9M | 92.3% |
| 2 | $157.56 | 400 | $63K | 0.3% |
| 3 | $158.62 | 1,829 | $290K | 1.3% |
| 4 | $159.61 | 815 | $130K | 0.6% |
| 5 | $161.01 | 2,000 | $322K | 1.5% |
| 6 | $161.71 | 5,106 |
| $826K |
| 3.8% |
| 7 | $162.40 | 200 | $32K | 0.2% |
| Total | $160.98 avg | 133,750 | $21.5M | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |